Loading provider…
Loading provider…
Emergency Medicine Physician in National City, CA
NPI: 1245286889Primary Practice Location
PARADISE VALLEY HOSPITAL
2400 E 4th St, National City, CA
Primary Employer
Pacific Paradise Emergency Physicians Medical Group Inc
pacificparadise-emergencyphysicians.com
HQ Phone
Get D.O. Paul's Phone Numberphone_androidMobile
Get D.O. Paul's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State License
1997 - 2026
MI State License
1994 - 1997

American Board of Emergency Medicine
Emergency Medicine
Detroit Medical Center/Wayne State University (Detroit Receiving Hospital)
Residency • Emergency Medicine
1994 - 1997
Chicago College of Osteopathic Medicine at Midwestern University
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99285Emergency department visit, problem with significant threat to life or function | 122 | 130 |
| 2 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 99 | 105 |
| 3 | 99284Emergency department visit with moderate level of medical decision making | 63 | 67 |
| 4 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 30 | 30 |
| 5 | 71045X-ray of chest, 1 view | 23 | 23 |
Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
Authors: Sinikka Green
Publication Date: 2015-01
Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority...
Authors: G. Ralph Corey, Samantha Good, Hai Jiang, Greg Moeck, Matthew A. Wikler
Lead Sponsor: Debiopharm International SA
Intervention / Treatment: DRUG: Vancomycin IV, DRUG: Linezolid, DRUG: Debio 1450 IV, DRUG: Debio 1450 Oral, DRUG: Debio 1450 Oral Placebo, DRUG: Linezolid Placebo